It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 02523cam 2200589 a 4500
001 ocm28184786
003 OCoLC
005 20200518003107.0
008 930511s1993 txua b 001 0 eng
010 $a 93004767
040 $aDNLM/DLC$beng$cDLC$dNLM$dTMV$dBAKER$dBTCTA$dLVB$dYDXCP$dDEBBG$dOCLCO$dOCLCQ$dOCLCF$dOCLCO$dOCLCA
016 7 $a9308309$2DNLM
019 $a28888301
020 $a1879702606$q(hard cover)
020 $a9781879702608$q(hard cover)
035 $a(OCoLC)28184786$z(OCoLC)28888301
050 00 $aRC271.A67$bR35 1993
060 00 $aQW 630$bR165c 1993
082 00 $a616.99/4061$220
084 $aXH 3200$2rvk
100 1 $aRamakrishnan, S.,$d1949-
245 10 $aCytotoxic conjugates /$cS. Ramakrishnan.
260 $aAustin :$bR.G. Landes Co.,$c1993.
300 $a119 pages :$billustrations ;$c27 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aMedical intelligence unit
504 $aIncludes bibliographical references and index.
505 0 $aTumor cell microenvironment -- Toxin molecules -- Preparation and analysis of immunotoxins -- Efficacy of immunotoxins in experimental animal model systems -- Clinical trials -- New generation of immunotoxins: genetically engineered chimeric toxins -- Antiviral activity of RIP and targeting toxins to HIV-1 virus infected cells -- Future directions and prospects.
650 0 $aAntibody-toxin conjugates$xTherapeutic use$xTesting.
650 0 $aAntibody-drug conjugates$xTherapeutic use$xTesting.
650 0 $aCancer$xImmunotherapy.
650 2 $aCell Transformation, Neoplastic.
650 2 $aImmunotoxins$xtherapeutic use.
650 2 $aNeoplasms$xdrug therapy.
650 6 $aConjugue s antitoxines$xEmploi en the rapeutique$xEssais.
650 6 $aConjugue s anticorps-me dicament$xEmploi en the rapeutique$xEssais.
650 6 $aCancer$xImmunothe rapie.
650 7 $aCytotoxin$2gnd
650 7 $aKrebs$gMedizin$2gnd
650 7 $aCancer$xImmunotherapy.$2fast$0(OCoLC)fst00845386
830 0 $aMedical intelligence unit (Unnumbered)
938 $aBaker & Taylor$bBKTY$c89.95$d94.90$i1879702606$n0002329238$sactive
938 $aBaker and Taylor$bBTCP$n93004767$c$89.95
938 $aYBP Library Services$bYANK$n1233277
029 1 $aAU@$b000022785192
029 1 $aDEBBG$bBV008402423
029 1 $aNLM$b9308309
029 1 $aYDXCP$b1233277
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 43 OTHER HOLDINGS